Clinical Trials
3 trialsNCT02717949 2019-01-08
Optimal
University of Texas Southwestern Medical Center
Phase 4 Terminated
NCT03261349 2017-08-25
Antiviral Agent HARVONI® for the Treatment of HCV-associated Indolent B-Cell Lymphoma
National Taiwan University Hospital
Phase 2 Unknown
NCT02588560 2015-10-28
Viral Load Changes in Lymphoma Patients With HCV Infection After Chemotherapy
Chang Gung Memorial Hospital
Unknown